Clinical implication of monitoring rivaroxaban and apixaban by using anti-factor Xa assay in patients with non-valvular atrial fibrillation

by Kozue Ikeda, MD, Hideaki Tachibana, MD
Published 2016-02-01

Antithrombotic Therapy According to the Guidelines Issued by the Japanese Circulation Society in Patients with Nonvalvular Paroxysmal Atrial Fibrillation without Thromboembolic Ris...

by Mahito Ozawa, MD, Takashi Komatsu, MD, Hideaki Tachibana, MD, Yoshihiro Sato, MD, Makoto Orii, MD, Fusanori Kunugita, MD, Motoyuki Nakamura, MD
Published 2009-01-01

Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study

by Mahito Ozawa, MD, Takashi Komatsu, MD, Yoshihiro Sato, MD, Fusanori Kunugita, MD, Hideaki Tachibana, MD, Atsushi Tashiro, MD, Hitoshi Okabayashi, MD, Motoyuki Nakamura, MD,PhD
Published 2015-10-01

Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation —Analysis Based on Time of Onset—

by Takashi Komatsu, MD, Yoshihiro Satou, MD, Hideaki Tachibana, MD, Motoyuki Nakamura, MD, Ken Okumura, MD, Shin Nakamura, MD, Osamu Suzuki, MD, Daisuke Horiuchi, MD, Kunihiko Yomogida, MD
Published 2006-01-01

Long-term Efficacy of Combination Therapy with Anti-arrhythmic Agents and Pravastatin in Patients with Paroxysmal Atrial Fibrillation

by Takashi Komatsu, MD, Hideaki Tachibana, MD, Yoshihiro Sato, MD, Mahito Ozawa, MD, Kyoko Ohshima, MD, Motoyuki Nakamura, MD, Daisuke Horiuchi, MD, Takao Kobayashi, MD, Ken Okumura, MD
Published 2007-01-01